Search Tag: NRx Pharmaceuticals

2022 07 Jun

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that the company's Board of Directors appointed  Seth Van Voorhees , Ph.D. as Chief Financial Officer and Treasurer effective  June 13, 2022 . "Dr.  Van Voorhees  is a highly accomplished CFO with extensive experience in corporate finance, capital markets, investment...Read more